Efficacy of sublingual immunotherapy with HDM mix extract (Der p and Der f) (SLITone) in pediatric patients with mild-to-moderate atopic eczema (AE) and sensitization to HDM (SPT positive).
Phase of Trial: Phase III
Latest Information Update: 03 Aug 2013
At a glance
- Drugs House dust mite allergy immunotherapy-ALK Abello (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Therapeutic Use
- 03 Aug 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 04 Aug 2011 New trial record